As the world races to find a vaccine for COVID-19, our colleague Dr Cem Gun, an Emergency Medicine Physician at Acıbadem University Atakent Hospital, has bravely volunteered for the country’s first clinical trial. On 9 October, he was administered the first dose of a COVID-19 vaccine developed in China and approved for trial by the Health Institutes of Turkey, at a high-key milestone event.
On why he volunteered for this trial, Dr Cem Gun said, “As a healthcare worker, I fall into the high-risk group for COVID-19 infection. I decided to be vaccinated not only to protect myself but also my patients and loved ones. I made this decision with peace of mind as it is a controlled trial; it is currently in Phase 3, making it a tested and safe vaccine.”
The vaccine will be administered in two doses, and volunteers will be monitored on its effectiveness over a year.
The World Bank has approved US$12 billion in financing to help developing countries buy and distribute COVID-19 vaccines, tests and treatments, aiming to support the vaccination of up to 1 billion people.
Related Stories
IHH Healthcare Advocates Long-term Sustainability Thinking at Future Economy Conference
At the recent Future Economy Conference 2026, IHH's Group Chief Sustainability Officer Yasemin Tecmen Stubbe shared why sustainability remains critical to business resilience and long-term value creation, particularly amid growing geopolitical uncertainty, climate risks and supply chain disruptions.
IHH Singapore Launches Great at Work Fest 2026
IHH Singapore officially launched Great at Work Fest 2026 (GAW Fest) on 11 May at the Centre for Healthcare Innovation, bringing together employees and leaders to celebrate workplace culture, service excellence, and employee wellbeing across its Singapore operations.
IHH Healthcare Aligns Teams in Malaysia and Singapore on Future-ready Healthcare Priorities
IHH Healthcare recently brought together employees across Malaysia’s Southern Region and Singapore for its Country Town Halls, reinforcing the Group’s focus on strengthening current healthcare capabilities while preparing for the evolving needs of the future.
Gleneagles Hong Kong and HKTDC Co-organised a Thematic Session at The Asia Summit on Global Health 2026
Titled “Intelligence at Scale: How AI is Powering Real-World Healthcare Revolution”, the thematic panel session co-organised by Gleneagles Hong Kong and Hong Kong Trade Development Council (HKTDC) was moderated by Dr Kenneth Tsang, Regional Chief Executive Officer of IHH Healthcare North Asia.
Acibadem Performed Türkiye's First Experimental 5G‑Supported Remote Robotic Surgical Simulation
The simulation was conducted between Acibadem Maslak Hospital and Acibadem University CASE (Advanced Medical Simulation and Training Center).
Parkway Rehab Supports Children’s Aid Society Through Project Legacy
At Parkway Rehab, while clinical care remains at the heart of the organisation, the team believes in looking beyond daily practice - to contribute meaningfully to the community, supporting those in need, within available means, and with purpose.
